FingolimodMultiple sclerosis relapse: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2011年 / 1381卷 / 1期

关键词：

Public Health; Steroid; Multiple Sclerosis; Emergency Department; Patient Outcome;

D O I：

10.2165/00128415-201113810-00047

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：14 / 14

相关论文

共 50 条

[1] FingolimodMultiple sclerosis relapse: case report
Reactions Weekly, 2012, 1428 (1) : 18 - 18
[2] FingolimodMultiple sclerosis exacerbation: case report
Reactions Weekly, 2012, 1409 (1) : 23 - 23
[3] RituximabFirst report of multiple sclerosis relapse: case report
Reactions Weekly, 2007, 1176 (1) : 27 - 27
[4] FingolimodSevere multiple sclerosis relapse: case report
Reactions Weekly, 2020, 1802 (1) : 139 - 139
[5] Natalizumab withdrawalMultiple sclerosis relapse?: case report
Reactions Weekly, 2011, 1360 (1) : 28 - 28
[6] IpilimumabRelapsing remitting multiple sclerosis relapse: case report
Reactions Weekly, 2016, 1587 (1) : 172 - 172
[7] Fingolimod withdrawalRebound relapse of multiple sclerosis: case report
Reactions Weekly, 2018, 1699 (1) : 131 - 131
[8] Natalizumab withdrawalFatal multiple sclerosis relapse: case report
Reactions Weekly, 2013, 1444 (1) : 28 - 28
[9] Alemtuzumab/cladribine/fingolimodMultiple infections and lack of efficacy: case report
Reactions Weekly, 2022, 1897 (1) : 25 - 25
[10] AlemtuzumabAutoimmune haemolytic anaemia and relapse of multiple sclerosis: case report
Reactions Weekly, 2020, 1802 (1) : 19 - 19

← 1 2 3 4 5 →